Results 81 to 90 of about 14,058 (258)
Nebivolol other beta blockers in patients with hypertension and erectile dysfunction
Therapeutic Advances in Urology, 2017 Erectile dysfunction (ED) impacts over 100 million men worldwide and occurs at a higher incidence in men with hypertension. Beta blockers are one of several antihypertensive drug classes associated with ED.
Randall P. Sharp, Barry J. Gales
doaj +1 more source
Resistant arterial hypertension in a patient with adrenal incidentaloma multiple steno-obstructive vascular lesions and antiphospholipid syndrome [PDF]
, 2015 Resistant hypertension is defined as above of blood pressure (≤ 140/90 mmHg) despite therapy with three or more antihypertensive drugs of different classes at maximum tolerable doses with one bling a diuretic.
CONCISTRE, ANTONIO +8 more
core
Beeta-adrenoblokaatorid arteriaalse hüpertensiooni ravis [PDF]
, 2018 Beeta-adrenoblokaatorid on kroonilise südamepuudulikkuse, ägeda müokardiinfarkti ja kodade virvendusarütmia ravi nurgakivid (1). Ehkki arteriaalse hüpertensiooni ravis on neid kasutatud üle poole sajandi, vaieldakse jätkuvalt selle üle, kas nad peaksid ...
Teeäär, Tuuli
core +2 more sources
Arthritis &Rheumatology, Volume 78, Issue 4, Page 985-992, April 2026.Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's phenomenon (RP) and to explore their potential pathophysiologic mechanisms through a mixed disproportionality/clustering analysis from the World Health Organization (WHO) pharmacovigilance database.
Alex Hlavaty +4 more
wiley +1 more source
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
Vascular Health and Risk Management, 2006 Robert WeissAndroscoggin Cardiology Associates, Auburn, ME, USAAbstract: Nebivolol is a novel beta1-blocker with a greater degree of selectivity for beta1- adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating ...
Robert Weiss
doaj
NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
Рациональная фармакотерапия в кардиологии, 2015 Aim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-
Y. V. Gavrilov +2 more
doaj +1 more source
Management of hypertension in children and adolescents [PDF]
, 2014 Hypertension has been recognized as an important health issue in the pediatric population over the past years. This emphasizes the need for an organized and effective plan for diagnosis and management. This review provides information to guide physicians
De Bruyne, Pauline, Vande Walle, Johan
core +1 more source
The Journal of Clinical Pharmacology, Volume 66, Issue 4, April 2026.Abstract Labetalol is widely prescribed as a first‐line antihypertensive in pregnancy; however, rare but potentially severe idiosyncratic hepatotoxicity has been reported, with a disproportionately strong reporting signal for liver injury relative to other β‐blockers.
Emma D. Hendriksen +2 more
wiley +1 more source
Nebivolol, a beta adrenergic receptor antagonist blocks angiotensin II-mediated signaling in heart [abstract] [PDF]
, 2010 We recently showed that Nebivolol, a [beta]-adrenergic receptor (AR) antagonist attenuates myocardial oxidative stress and promotes insulin metabolic signaling in 9 week old Zucker obese (ZO) insulin resistant rats.
Arnold, Shannon +4 more
core
Clinical efficacy of a betablockers therapy in patients with chronic heart failure on the background of postinfarction cardiosclerosis [PDF]
, 2017 Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acute myocardial infarction (AMI), the comparative effectiveness of various BBs in patients with postinfarction cardiosclerosis (PICS) is uncertain. There was
Gosteva, E. V. +4 more
core +2 more sources